TheraRadar

Pharma Intelligence, Simplified

← Back
Data updated: Mar 10, 2026

PERRIGO NEW YORK

Pharmaceuticals
Generics

PERRIGO NEW YORK is a generic drug manufacturer with 10 FDA-approved products.

1986
Since
10
Drugs
-
Trials
33
Approved (2yr)

Key Drugs

No active drugs

Recent Activity

BETAMETHASONE DIPROPIONATE 2026-01-26
ACETAMINOPHEN 2025-12-05
FLUOCINOLONE ACETONIDE 2025-10-01
Labeling
FLUOCINOLONE ACETONIDE 2025-10-01
Labeling
FLUOCINOLONE ACETONIDE 2025-09-16
Labeling
FLUOCINOLONE ACETONIDE 2025-09-03
Labeling
FLUOCINOLONE ACETONIDE 2025-09-03
Labeling
FLUOCINOLONE ACETONIDE 2025-08-04
Labeling
FLUOCINOLONE ACETONIDE 2025-08-04
Labeling
FLUOCINOLONE ACETONIDE 2025-07-18
Labeling
SEC Filings Pro
Loading...

Therapeutic Focus

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

No indication data

Pipeline Strength Pro

Loading...